<?xml version="1.0" encoding="UTF-8"?>

<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
  <id value="Triogen-250mg-Capsule"/>
  <meta>
    <profile value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"/>
  </meta>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Triogen-250mg-Capsule</b></p><a name="Triogen-250mg-Capsule"> </a><a name="hcTriogen-250mg-Capsule"> </a><a name="Triogen-250mg-Capsule-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-ch-idmp-medicinalproductdefinition.html">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title="Codes:{http://standardterms.edqm.eu 10210000}">Capsule, hard</span></p><p><b>CH - EPL Full Limitation Text</b>: TRIOGEN wird verg端tet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und 端berwacht werden.</p><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID</code>/CH-7601001403062-6743101</p><p><b>domain</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human</span></p><p><b>indication</b>: </p><div><p>Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003001}">Authorised for the treatment in children</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc A16AX12}">trientine</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}">NA KAS art. 12 para. 5 TPLO</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}">Synthetic</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}">Originator product</span></p><p><b>attachedDocument</b>: </p><ul><li><a href="DocumentReference-DocRef-FI-Triogen.html">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-qrs-123; status = current; type = Fachinformation; date = 2019-12-01 00:00:00+0000</a></li><li><a href="DocumentReference-DocRef-PI-Triogen.html">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-qrs-321; status = current; type = Patienteninformation; date = 2019-12-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: Triogen 250 mg, Kapseln</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></td><td><span title="Codes:{urn:ietf:bcp:47 de-CH}">German (Switzerland)</span></td></tr></table></blockquote></div>
  </text>
  <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm">
    <valueCodeableConcept>
      <coding>
        <system value="http://standardterms.edqm.eu"/>
        <code value="10210000"/>
        <display value="Capsule, hard"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <extension url="http://fhir.ch/ig/ch-epl/StructureDefinition/fullLimitationText">
    <valueString value="TRIOGEN wird verg端tet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und 端berwacht werden."/>
  </extension>
  <identifier>
    <system value="http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID"/>
    <value value="CH-7601001403062-6743101"/>
  </identifier>
  <domain>
    <coding>
      <system value="http://spor.ema.europa.eu/v1/lists/100000000004"/>
      <code value="100000000012"/>
      <display value="Human"/>
    </coding>
  </domain>
  <indication value="Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen."/>
  <legalStatusOfSupply>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"/>
      <code value="756005022003"/>
      <display value="Medicinal product subject to medical or veterinary prescription (B)"/>
    </coding>
  </legalStatusOfSupply>
  <additionalMonitoringIndicator>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator"/>
      <code value="756005001003"/>
      <display value="No Warning"/>
    </coding>
  </additionalMonitoringIndicator>
  <pediatricUseIndicator>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator"/>
      <code value="756005003001"/>
      <display value="Authorised for the treatment in children"/>
    </coding>
  </pediatricUseIndicator>
  <classification>
    <coding>
      <system value="http://www.whocc.no/atc"/>
      <code value="A16AX12"/>
    </coding>
  </classification>
  <classification>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category"/>
      <code value="756005021001"/>
      <display value="NA KAS art. 12 para. 5 TPLO"/>
    </coding>
  </classification>
  <classification>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode"/>
      <code value="756005004001"/>
      <display value="Synthetic"/>
    </coding>
  </classification>
  <classification>
    <coding>
      <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type"/>
      <code value="756001003002"/>
      <display value="Originator product"/>
    </coding>
  </classification>
  <attachedDocument>
    <reference value="DocumentReference/DocRef-FI-Triogen"/>
  </attachedDocument>
  <attachedDocument>
    <reference value="DocumentReference/DocRef-PI-Triogen"/>
  </attachedDocument>
  <name>
    <productName value="Triogen 250 mg, Kapseln"/>
    <type>
      <coding>
        <system value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type"/>
        <code value="SMC"/>
        <display value="Zugelassener Arzneimittelname"/>
      </coding>
    </type>
    <usage>
      <country>
        <coding>
          <system value="urn:iso:std:iso:3166"/>
          <code value="CH"/>
          <display value="Switzerland"/>
        </coding>
      </country>
      <language>
        <coding>
          <system value="urn:ietf:bcp:47"/>
          <code value="de-CH"/>
          <display value="German (Switzerland)"/>
        </coding>
      </language>
    </usage>
  </name>
</MedicinalProductDefinition>